Mehdi Forouzandeh Moghadam

6PUBLICATIONS
11CO-AUTHORS
Instrumental methods (excl. immunological and bioassay methods)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersGene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 07, 2026
An integrated magnetic-microfluidic chemiluminescence platform for rapid quantification of exosomal miR-21 associated with breast cancer.

Samira Narimani Kohnehshahri, Fatemeh Etezadi, Mohammad Amin Hajari

|Dec 11, 2023
Isolation and characterization of a novel single-chain variable fragment (scFv) against Lymphocyte function-associated antigen-1 (LFA-1) using phage display method.

Fatemeh Afsharnoori, Mehdi Forouzandeh Moghadam

|Aug 14, 2021
Isolation and characterization of a novel GRP78-specific single-chain variable fragment (scFv) using ribosome display method.

Shima Shabani, Mehdi Forouzandeh Moghadam, Seyed Latif Mousavi Gargari

|Mar 17, 2021
Radiolabeled HER2-directed exosomes exhibit improved cell targeting and specificity.

Mahlegha Ghavami, Chrysoula Vraka, Virginie Hubert

|Sep 19, 2018
Development of a novel anti-HER2 scFv by ribosome display and in silico evaluation of its 3D structure and interaction with HER2, alone and after fusion to LAMP2B.

Fatemeh Salimi, Mehdi Forouzandeh Moghadam, Masoumeh Rajabibazl

|Jun 29, 2018
Engineered Exosomes for Targeted Transfer of siRNA to HER2 Positive Breast Cancer Cells.

Shabanali Khodashenas Limoni, Mehdi Forouzandeh Moghadam, Seyed Mohammad Moazzeni

Pageof 1

Frequent Collaborators

1 joint publications

Masoumeh Rajabibazl

1 joint publications

Mahlegha Ghavami

1 joint publications

Chrysoula Vraka

1 joint publications

Virginie Hubert